NCT00899405 Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
| NCT ID | NCT00899405 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Davis |
| Condition | Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2004-05-19 |
| Primary Completion | 2034-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2004-05-19 with a primary completion date of 2034-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at tumor tissue samples and blood samples to learn more about DNA changes in patients with lung cancer.
Eligibility Criteria
DISEASE CHARACTERISTICS: * Histologically or cytologically confirmed lung cancer PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * May have received prior EGFR inhibitors
Contact & Investigator
Jonathan Riess, MD
PRINCIPAL INVESTIGATOR
University of California, Davis
Frequently Asked Questions
Who can join the NCT00899405 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00899405 currently recruiting?
Yes, NCT00899405 is actively recruiting participants. Contact the research team at OCRReferral@health.ucdavis.edu for enrollment information.
Where is the NCT00899405 trial being conducted?
This trial is being conducted at Sacramento, United States.
Who is sponsoring the NCT00899405 clinical trial?
NCT00899405 is sponsored by University of California, Davis. The principal investigator is Jonathan Riess, MD at University of California, Davis. The trial plans to enroll 800 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.